Prothena Corp Public (PRTA) Cash from Financing Activities (2012 - 2026)

Prothena Corp Public (PRTA) recorded quarterly Cash from Financing Activities of -$6.9 million in Q1 2026, down 40758.82% quarter-over-quarter from -$17000.0 in Q3 2025, and down 14370.83% on a YoY basis from N/an in Q1 2025.

Prothena Corp Public (PRTA) Cash from Financing Activities (2012 - 2026) Analysis & Trends

Prothena Corp Public's Cash from Financing Activities history runs 15 years deep, the most recent figure standing at -$6.9 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 14370.83% year-over-year to -$6.9 million; the TTM figure through Mar 2026 stood at -$7.0 million (down 1150.3% YoY), while the FY2025 annual figure was -$139000.0, down 108.94% from the prior year.
  • Cash from Financing Activities was -$6.9 million for Q1 2026 at Prothena Corp Public, down from -$17000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $220.8 million in Q4 2022 to a low of -$6.9 million in Q1 2026.
  • Historically, Cash from Financing Activities has averaged $17.6 million across 5 years, with a median of $659500.0 in 2023.
  • The sharpest annual moves came in 2022 and 2026: Cash from Financing Activities soared 12351.49% in 2022, then slumped 14370.83% in 2026.
  • A 5-year view of Cash from Financing Activities shows it stood at $220.8 million in 2022, then plunged by 99.78% to $483000.0 in 2023, then sank by 112.22% to -$59000.0 in 2024, then surged by 71.19% to -$17000.0 in 2025, then slumped by 40758.82% to -$6.9 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$6.9 million (Q1 2026), -$17000.0 (Q3 2025), and -$74000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Prothena Corp Public 479.08 Mn 149.61 Mn - -6.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.95 Mn
Mar 31, 2026 -6.95 Mn
Sep 30, 2025 -17,000.00
Sep 30, 2025 -17,000.00
Jun 30, 2025 -74,000.00
Jun 30, 2025 -74,000.00
Mar 31, 2025 -48,000.00
Mar 31, 2025 -48,000.00
Dec 31, 2024 -59,000.00
Dec 31, 2024 -59,000.00
Sep 30, 2024 333,000.00
Sep 30, 2024 333,000.00
Jun 30, 2024 444,000.00
Jun 30, 2024 444,000.00
Mar 31, 2024 836,000.00
Mar 31, 2024 836,000.00
Dec 31, 2023 483,000.00
Dec 31, 2023 483,000.00
Sep 30, 2023 2.71 Mn
Sep 30, 2023 2.71 Mn